Lv41
450 积分 2025-09-05 加入
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
4小时前
已完结
A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares
5个月前
已完结
Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout
5个月前
已完结
痛风达标治疗人群用药真实情况分析：多中心真实世界研究结果
5个月前
已完结
FRI0394 Efficacy and safety of canakinumab in gouty arthritis patients with chronic kidney disease stage ≥3
6个月前
已完结
Controversies and practical management of patients with gout and chronic kidney disease
6个月前
已完结
Risk acceleration by gout on major adverse cardiovascular events and all‐cause death in patients with diabetes and chronic kidney disease
6个月前
已完结
Prevalence of Chronic Kidney Disease in China
6个月前
已完结
Long‐term efficacy of canakinumab in hyperimmunoglobulin D syndrome
7个月前
已完结
Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis
7个月前
已完结
皖公网安备34019202002308
